Objective: Coupling of glucose oxidation to glycolysis is lower in hypertrophied than in non-hypertrophied hearts, contributing to the compromised mechanical performance of hypertrophied hearts. Here, we describe studies to test the hypothesis that low coupling of glucose oxidation to glycolysis in hypertrophied hearts is due to reduced activity and / or expression of the pyruvate dehydrogenase complex (PDC). Methods: We examined the effects of dichloroacetate (DCA), an inhibitor of PDC kinase, and of alterations in exogenous palmitate supply on coupling of glucose oxidation to glycolysis in isolated working hypertrophied and control hearts from aortic-constricted and sham-operated male Sprague-Dawley rats. It was anticipated that the addition of DCA or the absence of palmitate would promote PDC activation and consequently normalize coupling between glycolysis and glucose oxidation in hypertrophied hearts if our hypothesis was correct. Results: Addition of DCA or removal of palmitate improved coupling of glucose oxidation to glycolysis in control and hypertrophied hearts. However, coupling remained substantially lower in hypertrophied hearts. PDC activity in extracts of hypertrophied hearts was similar to or higher than in extracts of control hearts under all perfusion conditions. No differences were observed between hypertrophied and control hearts with respect to expression of PDC, PDC kinase, or PDC phosphatase. Conclusions: Low coupling of glucose oxidation to glycolysis in hypertrophied hearts is not due to a reduction in PDC activity or subunit expression indicating that other mechanism(s) are responsible.
Introduction
degree to oxidative degradation to CO in the mitochon-2 dria [6] [7] [8] . Glucose that is not oxidized is, instead, Glucose utilization is enhanced in hearts exposed to a converted to lactate and alanine [6] [7] [8] . Flux through these prolonged pressure or volume overload [1] [2] [3] [4] [5] . In myocardifferent catabolic pathways is not uniformly enhanced in dium, glucose is catabolized predominantly by the glythe hypertrophied heart [4, 5] . colytic pathway which is linked (or coupled) to a varying
Rates of glycolysis are accelerated in non-ischemic, ischemic, and reperfused hypertrophied hearts compared to non-hypertrophied hearts [4, 5, [9] [10] [11] [12] . However, there is no corresponding increase in rates of glucose oxidation 2. Experimental methods [4, 5, [9] [10] [11] [12] . In fact, glucose oxidation rates can actually be lower in hypertrophied hearts than non-hypertrophied 2.1. Animal model hearts, despite the enhanced rates of pyruvate generation [9, 13] . As a consequence, coupling of glucose oxidation to Pressure-overload left ventricular hypertrophy was proglycolysis is lower in hypertrophied hearts (10-11% duced in 3-week-old male Sprague-Dawley rats (50-75 g) glucose oxidized) than in non-hypertrophied hearts (20- by constriction of the suprarenal abdominal aorta with a 25% glucose oxidized) [9, 13, 14] . These alterations in metallic clip (0.4 mm diameter) [4] . In control rats, the glucose catabolism have functional relevance because low aorta was isolated but not constricted. Experiments were coupling of glucose oxidation to glycolysis contributes to performed 8 weeks after surgery. This model of mild contractile dysfunction of hypertrophied hearts, especially cardiac hypertrophy was used because it exposes the during reperfusion after ischemia [9, 11, 12] .
effects of hypertrophy without overt cardiac failure [26] . Low coupling of glucose oxidation to glycolysis in
The model is also characterized by lack of obvious fibrosis, hypertrophied hearts is surprising because fatty acid oxidaas documented previously [27, 28] and confirmed by the tion rates are also low in these hearts [4, 5] . Low rates of similar recovery of protein from hearts (Control, 792643 fatty acid oxidation would normally be expected to cause a vs. Hypertrophy, 746622 mg protein / g dry weight, n5 compensatory stimulation of myocardial glucose oxidation 15-16 per group, P5NS). and increased coupling [14] . Moreover, the increased Food and water were available ad libitum. These production of pyruvate accompanying accelerated rates of experiments were carried out in accordance with guidelines glycolysis is expected to favour higher rates of glucose set out by the Canadian Council on Animal Care and the oxidation by way of pyruvate-induced activation of the Guide for Care and Use of Laboratory Animals (NIH pyruvate dehydrogenase complex [15] [16] [17] [18] [19] . The mechaPublication No. 85-23, revised 1996). nism(s) responsible for low coupling of glucose oxidation to glycolysis in hypertrophied hearts are not yet known.
2.2. Heart preparation and perfusion protocol The multi-enzyme pyruvate dehydrogenase complex (PDC) catalyzes the oxidative decarboxylation of pyruvate As described [4, 9, 10, 29] , spontaneously beating hearts and contributes strongly to flux control of myocardial from halothane (3-4%)-anaesthetized rats were perfused glucose oxidation [15] [16] [17] 20] . The activity of PDC and, as isolated working preparations at a preload of 11.5 therefore, the rate of pyruvate decarboxylation are regmmHg and an afterload of 80 mmHg with 100 ml of ulated, in concert, by reversible phosphorylation of the modified Krebs-Henseleit solution. The solution contained a-subunit of the E1 (pyruvate dehydrogenase) component 1.2 mM palmitate pre-bound to defatted albumin (final 14 3 of PDC and inhibition by its end products, acetyl CoA and concentration 3%, w / v), 5.5 mM [U-C] / [5-H]glucose, NADH [15] [16] [17] 20] . The proportion of active dephos-0.5 mM lactate, 2.5 mM calcium chloride, and 100 mU / l 2 phorylated PDC in the heart is determined by the opposing insulin, except where indicated, and was continuously actions of pyruvate dehydrogenase kinase isoforms (PDKcirculated through the closed perfusion system. Calcium 1, -2, and -4) and pyruvate dehydrogenase phosphatase concentration above the physiological level (1.25 mM) (PDP) [15] [16] [17] [20] [21] [22] .
was used to offset binding to albumin and to obtain Alterations in PDC activity are observed in a number of optimum and sustained cardiac performance [30] . High pathological states. For example, in diabetes mellitus, concentrations of palmitate were utilized to minimize starvation, and hyperthyroidism, the activation state of differences in rates of fatty acid oxidation, evident at 0.4 PDC is reduced without changes in the expression of the mM palmitate, between control and hypertrophied hearts complex itself [17, 23] . The reduced activation state of [4, 11] . Insulin was included in the perfusate to ensure that myocardial PDC in these (patho)physiological states can the uptake and phosphorylation of glucose were not be accounted for by stable increases in the activity of PDK limiting. The solution was oxygenated with 95% O / 5% 2 [17, [22] [23] [24] , in turn explained by dramatic increases in CO , filtered in-line with each recirculation cycle, and 2 PDK mRNA and protein levels [22, 23] . As in hypertrophy, maintained at 37 8C throughout the perfusion. hearts from diabetic rats show lower glucose oxidation A pressure transducer (Viggo-Spectramed, Oxmard, CA, rates and lower coupling of glucose oxidation to glycolysis USA) inserted in the afterload line was used to measure than normal hearts [25] .
heart rate and peak systolic pressure. Cardiac output and The studies reported here were carried out to test the aortic flow were measured by means of external flow hypothesis that coupling of glucose oxidation to glycolysis probes (Transonic Systems, Ithaca, NY, USA) on the is low in hypertrophied hearts because the activation state preload and afterload lines, respectively. Coronary flow of PDC is reduced by increased expression of PDK in was calculated as the difference between cardiac output hypertrophied hearts compared to non-hypertrophied and aortic flow. Rate-pressure product, calculated as the hearts.
product of heart rate and peak systolic pressure, and hydraulic work, calculated as the product of cardiac output trifuged (10,0003g for 2 min) and supernatant fractions kept on ice prior to the PDC assays, usually carried out and peak systolic pressure, were used to measure external within 1 h. Samples of 10,0003g supernatant (100 ml) work performed by the heart. All perfusions were 30 min were incubated with pre-activated purified recombinant in duration. Measurements of heart function were taken pyruvate dehydrogenase phosphatase-1 (PDP-1) [34] for every 10 min. 20 min at 37 8C to allow PDC dephosphorylation. PreHearts were studied under four different conditions in activated PDP-1 (10 mg recombinant protein per PDC each group, being perfused with either the perfusate incubation) was prepared by incubating purified PDP-1 described above (Basal), with the addition of dichloroace- 21 21 tate (DCA, 1 or 3 mM), or with palmitate omitted from the with Mg (10 mM) and EGTA-buffered Ca (0.1 mM) perfusate (No palmitate). When present, DCA was added at in MOPS (25 mM) buffer at 30 8C for 10 min. PDC the beginning of the working heart perfusion. According to reactions were then initiated by the addition of pre-warmed our working hypothesis, activation of PDC by DCA or in buffer (pH 7.8) giving final concentrations of Tris-HCl 1 the absence of palmitate should normalize coupling of (120 mM), EDTA (0.6 mM), MgCl (1.2 mM), NAD 2 glucose oxidation to glycolysis in hypertrophied hearts. (0.6 mM), Coenzyme A (0.6 mM), thiamine pyrophosAn additional series of experiments was performed to phate (1.2 mM), and sodium pyruvate (1.2 mM). Incubadetermine if accumulation of lactate over the duration of tions were allowed to continue for 10 min and were then the perfusion could contribute to the changes in glucose stopped with removal of aliquots (210 ml) into ice-cold catabolism. Hearts were perfused as above, except that the perchloric acid (40 ml, 0.5 M). After incubation on ice for perfusate included 3 mM DCA and 3 mM lactate, a lactate at least 5 min, samples were neutralized with 10 ml concentration greater than that observed at the end of KHCO (2.2 M) and centrifuged (10,0003g for 3 min). later assay of the acetyl-CoA produced by the PDC At the end of the perfusion period, the ventricles were reaction. This was accomplished by allowing reaction of 14 quickly frozen using tongs cooled to the temperature of the PDC-derived acetyl-CoA with [ C]oxaloacetate to 14 liquid nitrogen. Selected hearts were also rapidly frozen produce [ C]citrate [31] [32] [33] . Using the conditions deafter removal from anaesthetized rats. The frozen tissue scribed, rates of acetyl-CoA production by PDC in tissue was weighed to determine ventricular weight, powdered, homogenates were linear for at least 20 min. and then stored at 270 8C. Remaining atrial tissue and portions of ventricular tissue were dried, weighed, and 2.4.1.2. Active PDC Tissue homogenates were prepared used in the calculation of total heart weight.
as for total PDC except that homogenization buffer also contained NaF (50 mmol / l) to inhibit PDP. Assay incuba-2.3. Measurement of glucose oxidation and glycolysis tions, quenching by acidification, and then neutralization were all as described for total PDC activity, except that no Glucose oxidation was measured by quantitatively deincubation with PDP was included prior to initiation of the 14 14 termining the rate of CO production from [U-C]glu-PDC reaction. Activities were expressed as international 2 cose [4, 9, 10] . Rates of glycolysis were determined by units (U, mmol product produced / min). To avoid bias in [ C]oxaloacetate and PDC-derived acetyl CoA [31] [32] [33] . which activated, dephosphorylated PDC was inactivated by the endogenous PDK upon incubation with ATP. Fresh 2.4.1.1. Total PDC Samples of frozen ventricular musheart supernatant fractions were prepared using homogenicle (100 mg) were extracted in 2.4 ml of ice-cold buffer zation buffer as described above, omitting sodium fluoride using a Polytron homogenizer (setting [6, for two bursts and DCA. Following PDC dephosphorylation, phosphorylof 2 s). The extraction buffer, pH 7.2, contained Tris-HCl ation was then initiated by adding ATP (5 mmol / l) and (50 mM), sucrose (200 mM), KCl (50 mM), EGTA (5 sodium fluoride (50 mmol / l). Aliquots were removed just mM), dichloroacetate (5 mM), glutathione (2.5 mM) and prior to and at 0.5, 1, 2, 5, 10, and 20 min after the Triton X-100 (0.1%, w / v). The homogenate was cenaddition of ATP to determine PDC activity in buffer containing pyruvate and DCA, as described above. Consignificant (NS). Values are expressed as the trols for the ATP-dependent inhibition included parallel mean6standard error of the mean (S.E.M.). incubation of the PDC samples under identical conditions except for omission of ATP. PDC activity changed by less than 10% over 20-min incubation in the absence of ATP, 3. Results confirming that ATP-independent changes in PDC activity were insignificant.
Animal data
The weight of hearts from aortic-banded rats 2.5. PDK mRNA expression (2.3060.05 g, n530) was significantly increased compared to that of sham-operated control rats (1.9060.04 g, Northern blot analysis was performed essentially as 32 n530, P,0.05). Body weights of aortic-banded rats described [37] . Hybridization was performed with [ P]-(47366 g) were not significantly different from shamlabelled cDNA probes of rat PDK1 [38] , PDK2 [37] , and operated control rats (45867 g, P5NS). PDK4 [21] . RNA lane loading was monitored by repeat hybridization of the membrane with glyceraldehyde-3-3.2. Mechanical function of control and hypertrophied phosphate dehydrogenase (GAPDH) using a GAPDH hearts cDNA probe [39] . Band signal intensity was quantified by densitometry and expressed in relation to GAPDH signal All functional parameters were lower in hypertrophied intensity.
hearts than control hearts under basal conditions (Table 1) . Exposure to 1 mM DCA significantly improved cardiac 2.6. Immunoblot analysis of PDC and PDP protein output and coronary flow in hypertrophied hearts. Perfuexpression sion with 3 mM DCA had minor effects on function, the only significant effect being a modest increase in heart rate Protein samples from mitochondria isolated from unin hypertrophied hearts. Most functional parameters reperfused rat hearts [40] were subjected to 10% SDSmained lower in DCA-treated hypertrophied hearts than in PAGE [41] and transferred to nitrocellulose membranes.
DCA-treated control hearts. The absence of palmitate also Membranes were blocked and incubated with rabbit polyhad minor effects on function with an increase in heart rate clonal antibodies against PDC or PDP [22, 34, 42] . Chemiand a decrease in peak systolic pressure in both groups. luminescence-based detection (NEN, Boston, MA) and Exposure to both 3 mM DCA and 3 mM lactate had no quantitation by densitometry followed incubation of the significant effects on heart performance (data not shown). membranes with anti-rabbit secondary antibody.
Glucose oxidation and glycolysis

Statistical analysis
In the absence of DCA, glucose oxidation was slightly Weight, enzyme activity, and expression data were but not significantly lower in hypertrophied hearts than in analyzed using a two-way analysis of variance (ANOVA).
control hearts (Fig. 1A) . Glycolysis, on the other hand, was Left ventricular function, glucose oxidation, and glycolysis significantly accelerated in hypertrophied hearts compared were examined using the repeated measures two-way to control hearts (Fig. 1B) . ANOVA. A corrected P-value .0.05 was considered nonGlucose oxidation was stimulated 2-3-fold by DCA in Values are those at end of the perfusion period. Numbers per group are in parentheses. Heart rate, bpm; peak systolic pressure, mmHg; cardiac output, ml / min; rate pressure product, mmHg bpm / 1000; hydraulic work, mmHg ml / min per 100; coronary flow, ml / min per g wet wt. *Different from Basal Control, P,0.05; †different from corresponding Basal group, P,0.05; ‡different from corresponding DCA-treated or No palmitate Control, P,0.05. to 3 mM DCA did not differ from those perfused without DCA. Interestingly, glycolysis did not differ between control and hypertrophied hearts at either concentration of DCA.
Rates of glycolysis and glucose oxidation were stimulated more dramatically in the absence of palmitate than in the presence of DCA (Fig. 1A,B) . Under these conditions, glycolysis did not differ between the two groups. Glucose oxidation, on the other hand, was dramatically lower in hypertrophied hearts than in control hearts. Normalization of glycolysis and glucose oxidation to work performed by the heart did not significantly change the findings (data not shown).
The proportion of glucose passing through glycolysis that is oxidized, which is a measure of coupling of glucose oxidation to glycolysis, is summarized in Table 2 . Under basal conditions, 16% of the glucose was oxidized in control hearts, while only 10% was oxidized in hypertrophied hearts. As expected, activation of PDC by DCA and the omission of palmitate from the perfusate increased the proportion of glucose oxidized in both groups. However, the proportion oxidized in hypertrophied hearts (a range of 1961 to 2562%) remained significantly lower than in control hearts (a range of 3062 to 3661%).
Compared to values in hearts perfused with 0.5 mM lactate and 3 mM DCA (Fig. 1) , 3 mM lactate and 3 mM DCA did not significantly alter rates of glycolysis (Control, 39426245; Hypertrophy, 41046198 nmol / min per g dry wt) or glucose oxidation (Control, 1075681; Hypertrophy, 737660 nmol / min per g dry wt). Importantly, the extent of coupling between glycolysis and glucose oxidation remained significantly lower in hypertrophied hearts (18.061.1%) than in control hearts (27.962.6%, n53 per group, P,0.05). Alterations in perfusate lactate concentrations cannot, therefore, account for the changes Table 2 Percentage of glucose oxidized in isolated working control and hyboth groups. However, absolute rates of glucose oxidation pertrophied rat hearts perfused with and without dichloroacetate (DCA) were lower in hypertrophied hearts than in control hearts and in the absence of palmitate (Fig. 1A) , particularly at the highest concentration of DCA Condition of study Control Hypertrophy (3 mM). The effects of DCA on glycolysis were concentration dependent and complex (Fig. 1B) extracts from hypertrophied hearts than from control hearts (Table 3) . Total PDC activity did not differ significantly between groups (Table 3) . Similarly, the activation state of PDC was generally higher in hypertrophied hearts than control hearts, but again, this difference was not significant. Similar findings (data not shown) were obtained when PDC activities were expressed in relation to dry heart weight or in relation to mitochondrial glutamate dehydrogenase (GDH) activity. The total PDC values using these alternative calculations were 9.661.8 U / g dry wt (Control) and 9.160.9 U / g dry wt (Hypertrophy) and 0.5760.11 U PDC / U GDH (Control) and 0.6960.05 U PDC / U GDH (Hypertrophy) .
Maximal and comparable activation of PDC was achieved in both control and hypertrophied hearts following perfusion with 3 mM DCA (Control, 26.065.8 vs. Hypertrophy, 28.964.2 mU / mg protein, n53, P5NS). No further activation of PDC was obtained with higher concentrations of DCA (up to 5 mM) and no significant differences in PDC activity between control and hypertrophied hearts were observed with 1 mM DCA (data not shown). PDC activity did not differ significantly following Based on Western blot analysis (Fig. 2) , no significant *Significantly different from non-hypertrophied control.
difference in the expression of E1a, E1b, or E2 subunits of PDC was observed between control and hypertrophied hearts. E3 subunits were not detected with this preparation presence of ATP, PDC had declined to 52.164.5% (Conof antiserum. Interestingly, expression of E3-binding protrol) and 47.764.5% (Hypertrophy) of maximum. In both tein was higher in hypertrophied hearts than in control cases, PDC activities declined to less than 25% maximum hearts. The expression of mRNA encoding PDK isoforms within 20 min. Expression of PDP isoforms (Fig. 4 ) was 1, 2 and 4, as assessed by densitometry, was not signot significantly different between the two groups. nificantly different between control and hypertrophied hearts (Fig. 3) . In keeping with the mRNA expression data, no significant differences in PDK activity were 4. Discussion detected between control and hypertrophied hearts; endogenous PDK activity in tissue homogenates was assessed by
In this study, we confirm that coupling of glucose fully dephosphorylating PDC and following the time-deoxidation to glycolysis is low in the hypertrophied heart pendency for inactivation of dephospho-PDC in the pres- [9, 13] . We now demonstrate that this reduction cannot be ence of ATP. These studies showed that total PDC explained by alterations in measured PDC activity. Noactivities following PDP treatment and also the subsequent tably, glucose oxidation is significantly repressed in hyrates of in vitro PDC inactivation during incubation with pertrophied hearts despite comparable activation of PDC in ATP were very similar in extracts of control and hyhypertrophied and non-hypertrophied hearts by DCA or in pertrophied hearts. For example, after 1 min in the the absence of perfusate palmitate. This observation stands in marked contrast to those made on hearts from diabetic glucose oxidation. Furthermore, the finding that glucose or hyperthyroid animals [17, [22] [23] [24] , in which PDC activaoxidation and coupling of glucose oxidation to glycolysis tion state is dramatically reduced, in concert with enhanced are substantially lower in hypertrophied hearts than in expression of PDK. Taken together, our data indicate that control hearts when PDC is comparably activated by DCA changes in factors other than PDC must be responsible for or the absence of palmitate (Fig. 1A) provides unequivocal the low coupling of glucose oxidation to glycolysis evidence that glucose oxidation is limited in the hyobserved in hypertrophied hearts.
pertrophied heart. In agreement with our previous studies [4, [9] [10] [11] [12] , we
In contrast to our initial hypothesis, and to the situation found, in the presence of palmitate, that glucose oxidation in diabetic or hyperthyroid hearts, impaired coupling of is not increased in hypertrophied hearts compared to glucose oxidation to glycolysis in the hypertrophied heart control hearts, even though glycolysis is accelerated in is not due to a reduction in the proportion of PDC in the hypertrophied hearts. This observation is surprising beactive form (Table 3) . Two further key observations also cause the enhanced pyruvate production would be expected underline the fact that the limitation of glucose oxidation to induce PDC activation through non-competitive inhibiin hypertrophied hearts cannot be explained by a reduction tion of PDK [15] [16] [17] [18] [19] 43] with consequent stimulation of in total PDC capacity. First, the expression of E1a, E1b, and E2 subunits of PDC does not differ significantly glycogen and triglyceride could potentially contribute to between control and hypertrophied hearts (Fig. 2) . Second, the decreased glucose oxidation measured in hypertrophied total PDC activity measured in myocardial extracts is not hearts, especially in the absence of exogenous palmitate. In lower in hypertrophied hearts than that in non-hyperthis regard, myocardial glycogen content did not sigtrophied hearts, whether expressed in relation to total nificantly differ between hypertrophied and control hearts protein (Table 3) or mitochondrial GDH activity. With under the conditions studied here (data not shown) and the respect to PDC subunit expression, one caveat remains, in extent of net glycogen degradation was small in both that the expression of E3-binding protein was significantly groups, accounting for no more than 10% of total glyincreased in hypertrophied hearts. The E3-binding protein colytic flux. Degradation of glycogen therefore does not (Protein X) links E3 to the E2 core and is required for full account for the low glucose oxidation rates observed in the PDC activity [42] . Differential expression of PDC subunits hypertrophied hearts. Degradation of endogenous trihas been documented in rat white adipose tissue during the glycerides, likely substantial in the absence of exogenous suckling to weaning transition period [44] , but the signifipalmitate, was not assessed in the current experiments and cance of the increased expression of E3-binding protein in might contribute to decreased glucose oxidation and hypertrophied hearts is unclear.
reduced coupling of glucose oxidation to glycolysis obOne potential explanation for low rates of glucose served in hypertrophied hearts perfused in the absence of oxidation in hypertrophied hearts is a limitation of mitoexogenous palmitate. However, net mobilization of endogchondrial oxidative metabolism. However, hypertrophied enous triglyceride is unlikely to account for these findings hearts are known to oxidize octanoate at rates comparable in the presence of exogenous palmitate with and without to those in non-hypertrophied hearts [45] . Moreover, rates DCA. Nevertheless, it will be important to specifically of oxygen consumption per gram of tissue in hearts with examine the possible role of endogenous triglycerides in compensated hypertrophy are not significantly different the metabolism of hypertrophied hearts in future studies. from non-hypertrophied hearts [45] [46] [47] . Taken together, Because changes in PDK or PDP might be responsible these data suggest that terminal oxidation of substrates for alterations in PDC activity, we also determined the distal to the PDC is not significantly impaired in hearts expression of PDK and PDP isoforms in hypertrophied with compensated cardiac hypertrophy.
hearts and control hearts. Four isoforms of PDK have been As a source of unlabelled acetyl-CoA, endogenous described [21, 37, 38] that differ in kinetic and regulatory properties and in tissue-specific expression [21] . In the likely that energy requirements in the current experiments heart, PDK isoforms 1, 2 and 4 predominate [21] . In the were lower in hypertrophied hearts than the situation in current study, no differences in expression of any of the vivo and lower than in control hearts. In light of the PDK isoforms were detected at the mRNA level between importance of workload to oxidative catabolism of glucose control and hypertrophied hearts (Fig. 3) , unlike the [32], it is possible that the lower energy requirements may situation in hearts from diabetic and hyperthyroid animals, have affected coupling between glucose oxidation and in which PDK-4 expression is increased. glycolysis in hypertrophied hearts. Of potential relevance, The two recognized mammalian isoforms of PDP differ Massie et al. found that glucose oxidation and coupling to with respect to tissue distribution, kinetics, and regulatory glycolysis were not suppressed in hypertrophied pig hearts properties [34] . Here, we show that, in contrast to skeletal studied in vivo under conditions in which estimated energy muscle, both PDP1 and PDP2 isoforms are expressed in requirements were comparable [56] . Given these considheart muscle (Fig. 4) and that expression of both isoforms erations, it is clearly important to determine the extent of was unchanged as a result of cardiac hypertrophy.
coupling between glucose oxidation and glycolysis in We are aware of two previous reports in which PDC hypertrophied rat hearts studied in vivo as well as under activity has been determined in hypertrophied hearts. In more extreme workload conditions in vitro in future one study, using pulmonary artery banding in adult ferrets, experiments. total PDC activity was unchanged over 4-6 weeks of Notwithstanding this important caveat, the results of this pressure overload [48] , in keeping with the findings in the current investigation may have important clinical ramificacurrent investigation. In another study, abdominal aortic tions. Stimulation of pyruvate oxidation by activation of banding in rats was employed for 5 weeks prior to PDC, which improves coupling between glucose oxidation determination of PDC activity [49] . The investigators and glycolysis, is a metabolic approach that improves found that PDC activation state was reduced in hyperfunction of non-hypertrophied hearts during ischemia and trophied hearts. The explanation for the discrepant findings reperfusion [8] . The data in this investigation indicate that between the latter study and ours is not immediately this approach may not be as beneficial to the hypertrophied apparent. The studies differ in the model of cardiac heart as it is to the non-hypertrophied heart [9] , because hypertrophy used, in the fact that hearts were not perfused glucose oxidation is evidently limited in hypertrophied in the earlier study, and in methods of calculating and hearts by other factors. Determination of the factors expressing PDC activity.
responsible for impaired coupling of glucose oxidation to Accelerated rates of glycolysis are consistent with glycolysis in hypertrophied hearts is, therefore, of great reported changes in glycolytic enzymes in the myocardium importance because it will identify novel therapeutic of hearts exposed to a pressure overload [1, 50, 51] . Inhibtargets. itory effects on myocardial glycolysis (observed at 1 mM DCA) might be expected according to the Pasteur effect, assuming a constant or lowered energy demand. Moreover, Acknowledgements DCA may also directly inhibit glycolysis by reducing the activities of hexokinase and pyruvate kinase [52] . The Supported by grants from the Medical Research Council effects of DCA observed here, however, were more of Canada (now the Canadian Institutes for Health Recomplex in that glycolysis was stimulated by 3 mM DCA, search) and the Heart and Stroke Foundation of BC and relative to values seen at 1 mM DCA. Conceivably, the Yukon. N.S. is a Research Fellow of the Alberta Heritage effects of 3 mM DCA could be mediated by inhibition of Foundation for Medical Research and the Heart and Stroke fatty acid oxidation with reduction in myocardial citrate Foundation of Canada. M.F.A. is a Career Investigator of and activation of phosphofructokinase [53, 54] , but definithe Heart and Stroke Foundation of BC and Yukon. We are tion of the exact mechanism will require further study.
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Potential limitations
The findings of this present study cannot necessarily be References extrapolated to the in vivo setting, because in vitro models fail to adequately reproduce in vivo conditions including [55], and mass of hypertrophied hearts are considered, it is 
